Jim Cramer's StopTrading! Stock Picks and Comments, Nov. 20

 |  Includes: AGN, BBRY, EOP, FCX, MRK
by: Miriam Metzinger

Recap of Jim Cramer’s comments on Stop Trading! Monday November 20. Click on a stock ticker for more analysis:

Research In Motion (RIMM): Cramer says that RIMM is rallying like a "running back that has just broken through the Rutgers defense," and expects the surge to continue through the holidays.

Allergan (NYSE:AGN), Merck (NYSE:MRK) and Pfizer (NYSE:PFE): Cramer called Allergan a "genius company" with its popular Botox and other products. He notes that it is up $7 at $119, and may be an attractive acquisition for Merck or Pfizer.

Phelps Dodge (PD), Equity Office (EOP) and Freeport (NYSE:FCX): Recent mergers like those of PD-FCX and EOP demonstrate that "everything is cheap to someone in this market," remarks Cramer. Freeport picked up PD because it needed more copper, and since metals are "so hated by mutual funds" the acquisition was inexpensive. Cramer added that there is a lack of supply in good stocks and "All the managements I know think stocks are undervalued," he added. "So many companies want to buy other companies."

More: Cramer's latest stock picks, including: Mad Money Recap, Lightening Round, Stop Trading and his Radio Show.

Get Cramer's Picks by email -- it's free and takes only a few seconds to sign up.

SeekingAlpha is not affiliated with CNBC, Jim Cramer or TheStreet.com